Logo image of OM

OUTSET MEDICAL INC (OM) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:OM - US6901452069 - Common Stock

4.4 USD
+0.04 (+0.92%)
Last: 12/10/2025, 8:10:59 PM
4.4 USD
0 (0%)
After Hours: 12/10/2025, 8:10:59 PM

OM Key Statistics, Chart & Performance

Key Statistics
Market Cap79.86M
Revenue(TTM)120.07M
Net Income(TTM)-88.16M
Shares18.15M
Float16.84M
52 Week High25.35
52 Week Low4
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-10.32
PEN/A
Fwd PEN/A
Earnings (Next)01-05 2026-01-05/amc
IPO2020-09-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


OM short term performance overview.The bars show the price performance of OM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

OM long term performance overview.The bars show the price performance of OM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of OM is 4.4 USD. In the past month the price decreased by -29.26%. In the past year, price decreased by -73.57%.

OUTSET MEDICAL INC / OM Daily stock chart

OM Latest News, Press Relases and Analysis

OM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 24.56 213.10B
ISRG INTUITIVE SURGICAL INC 64.57 197.07B
BSX BOSTON SCIENTIFIC CORP 31.42 137.42B
SYK STRYKER CORP 26.86 135.30B
BDX BECTON DICKINSON AND CO 13.76 56.63B
IDXX IDEXX LABORATORIES INC 55.66 56.04B
EW EDWARDS LIFESCIENCES CORP 32.65 48.70B
GEHC GE HEALTHCARE TECHNOLOGY 18.4 38.48B
RMD RESMED INC 25.4 36.71B
DXCM DEXCOM INC 36.32 26.35B
PODD INSULET CORP 64.59 20.77B
ZBH ZIMMER BIOMET HOLDINGS INC 11.51 18.45B

About OM

Company Profile

OM logo image Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 354 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Company Info

OUTSET MEDICAL INC

3052 Orchard Drive

San Jose CALIFORNIA 95134 US

CEO: Leslie Trigg

Employees: 354

OM Company Website

OM Investor Relations

Phone: 16692318200

OUTSET MEDICAL INC / OM FAQ

What does OM do?

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 354 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.


What is the stock price of OUTSET MEDICAL INC today?

The current stock price of OM is 4.4 USD. The price increased by 0.92% in the last trading session.


Does OUTSET MEDICAL INC pay dividends?

OM does not pay a dividend.


How is the ChartMill rating for OUTSET MEDICAL INC?

OM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is OM stock listed?

OM stock is listed on the Nasdaq exchange.


Can you provide the market cap for OUTSET MEDICAL INC?

OUTSET MEDICAL INC (OM) has a market capitalization of 79.86M USD. This makes OM a Micro Cap stock.


What is the next earnings date for OM stock?

OUTSET MEDICAL INC (OM) will report earnings on 2026-01-05, after the market close.


OM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

OM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OM. OM has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OM Financial Highlights

Over the last trailing twelve months OM reported a non-GAAP Earnings per Share(EPS) of -10.32. The EPS increased by 65.94% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -31.8%
ROE -61.93%
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%88.21%
Sales Q2Q%2.67%
EPS 1Y (TTM)65.94%
Revenue 1Y (TTM)4.65%

OM Forecast & Estimates

13 analysts have analysed OM and the average price target is 16.07 USD. This implies a price increase of 265.11% is expected in the next year compared to the current price of 4.4.

For the next year, analysts expect an EPS growth of 82.99% and a revenue growth 3.61% for OM


Analysts
Analysts83.08
Price Target16.07 (265.23%)
EPS Next Y82.99%
Revenue Next Year3.61%

OM Ownership

Ownership
Inst Owners94.39%
Ins Owners1.87%
Short Float %12.45%
Short Ratio4.46